These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9225141

  • 21. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG, Dobberstein KU, Fittkau M, Bahn H, Holzhausen HJ, Gantchev L, Burkert W.
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.
    Bodey B, Gröger AM, Bodey B, Siegel SE, Kaiser HE.
    Anticancer Res; 1997 Jul; 17(2A):1187-94. PubMed ID: 9137469
    [Abstract] [Full Text] [Related]

  • 23. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.
    Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413
    [Abstract] [Full Text] [Related]

  • 24. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M, Iggo RD, Waridel F, Nozaki M, Matsumoto R, Sawamura Y, Shinohe Y, Ikeda J, Abe H.
    Mol Carcinog; 1997 Mar 15; 18(3):171-6. PubMed ID: 9115587
    [Abstract] [Full Text] [Related]

  • 25. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C, Wang H, Gonzalez-Crussi F, Lin JN, Hung IJ, Yang CP, Jiang TH.
    Mod Pathol; 2002 Jun 15; 15(6):606-10. PubMed ID: 12065773
    [Abstract] [Full Text] [Related]

  • 26. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES, Lai CR, Hsieh YT, Chen JT, Lin AJ, Hung MH, Liu FS.
    Gynecol Oncol; 2001 Feb 15; 80(2):189-93. PubMed ID: 11161858
    [Abstract] [Full Text] [Related]

  • 27. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
    Griewe GL, Dean RC, Zhang W, Young D, Sesterhenn IA, Shanmugam N, McLeod DG, Moul JW, Srivastava S.
    Prostate Cancer Prostatic Dis; 2003 Feb 15; 6(4):281-5. PubMed ID: 14663467
    [Abstract] [Full Text] [Related]

  • 28. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS, Foley JF, Devereux TR, Maronpot RR, Massey TE.
    Cancer Res; 1999 Aug 01; 59(15):3634-40. PubMed ID: 10446974
    [Abstract] [Full Text] [Related]

  • 29. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
    Laframboise S, Chapman W, McLaughlin J, Andrulis IL.
    Cancer J; 2000 Aug 01; 6(5):302-8. PubMed ID: 11079169
    [Abstract] [Full Text] [Related]

  • 30. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T, Tokuchi Y, Hayashi M, Kobayashi Y, Nishida K, Hayashi S, Ishikawa Y, Tsuchiya S, Nakagawa K, Hayashi J, Tsuchiya E.
    Cancer Res; 1999 Nov 01; 59(21):5572-7. PubMed ID: 10554037
    [Abstract] [Full Text] [Related]

  • 31. Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.
    Cao W, Chen X, Dai H, Wang H, Shen B, Chu D, McAfee T, Zhang ZF.
    Cancer; 2004 Aug 15; 101(4):834-44. PubMed ID: 15305417
    [Abstract] [Full Text] [Related]

  • 32. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H, Ogura T, Yokose T, Nagai K, Nishiwaki Y, Esumi H.
    Hum Pathol; 2001 Oct 15; 32(10):1043-9. PubMed ID: 11679937
    [Abstract] [Full Text] [Related]

  • 33. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr 15; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 34. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
    Tolbert DM, Noffsinger AE, Miller MA, DeVoe GW, Stemmermann GN, Macdonald JS, Fenoglio-Preiser CM.
    Mod Pathol; 1999 Jan 15; 12(1):54-60. PubMed ID: 9950163
    [Abstract] [Full Text] [Related]

  • 35. Comparative assessment of the functional p53 status in glioma cells.
    Kim EL, Yoshizato K, Kluwe L, Meissner H, Warnecke G, Zapf S, Westphal M, Deppert W, Giese A.
    Anticancer Res; 2005 Jan 15; 25(1A):213-24. PubMed ID: 15816541
    [Abstract] [Full Text] [Related]

  • 36. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium.
    Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Chang KC.
    Mol Vis; 2005 Jan 18; 11():50-5. PubMed ID: 15682042
    [Abstract] [Full Text] [Related]

  • 37. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.
    Takahashi T, Munakata M, Ohtsuka Y, Nisihara H, Nasuhara Y, Kamachi-Satoh A, Dosaka-Akita H, Homma Y, Kawakami Y.
    Cancer; 2002 Aug 01; 95(3):624-33. PubMed ID: 12209756
    [Abstract] [Full Text] [Related]

  • 38. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
    Vieyra D, Senger DL, Toyama T, Muzik H, Brasher PM, Johnston RN, Riabowol K, Forsyth PA.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5952-61. PubMed ID: 14676120
    [Abstract] [Full Text] [Related]

  • 39. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
    Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A.
    Acta Neuropathol; 2009 Oct 01; 118(4):469-74. PubMed ID: 19554337
    [Abstract] [Full Text] [Related]

  • 40. TP53 mutations in malignant astrocytomas.
    Biernat W, Debiec-Rychter M, Kordek R, Liberski PP.
    Pol J Pathol; 1997 Oct 01; 48(4):221-4. PubMed ID: 9529927
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.